Showing results (151-160 of 244) with videos related to
Sort By:
Pageof 25
Plos One|July 5, 2013
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate CancerSjoerd T Ligthart, Frank A W Coumans, Francois-Clement Bidard, et al.Plos One|February 28, 2017
Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancersHélène Bonsang-Kitzis, Delphine Mouttet-Boizat, Eugénie Guillot, et al.Anticancer Research|March 2, 2018
COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer PatientsPatricia DE Cremoux, Anne-Sophie Hamy, Jacqueline Lehmann-Che, et al.Breast Cancer Research : BCR|May 29, 2020
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris areaPerrine Vuagnat, Maxime Frelaut, Toulsie Ramtohul, et al.Cancers|March 6, 2021
PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for ImmunotherapyBeatriz Grandal, Manon Mangiardi-Veltin, Enora Laas, et al.The Lancet. Oncology|November 6, 2012
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 studyThomas Bachelot, Gilles Romieu, Mario Campone, et al.Bulletin Du Cancer|December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.Cancers|October 15, 2020
No Impact of Smoking Status on Breast Cancer Tumor Infiltrating Lymphocytes, Response to Neoadjuvant Chemotherapy and PrognosisVanille Simon, Lucie Laot, Enora Laas, et al.Plos One|June 25, 2020
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapyAnne-Sophie Hamy, Lauren Darrigues, Enora Laas, et al.Oncogene|February 12, 2020
A single droplet digital PCR for ESR1 activating mutations detection in plasmaEmmanuelle Jeannot, Lauren Darrigues, Marc Michel, et al.Pageof 25